Literature DB >> 18569971

Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury.

Joseph V Bonventre1.   

Abstract

There is an urgent need for the detection and monitoring of kidney injury in both the acute and chronic disease setting. Urinary kidney injury molecule-1 (Kim-1), a type-1 transmembrane protein, is not normally present, but is expressed on the proximal tubule apical membrane with injury. Kim-1 has proved to be an outstanding indicator of kidney injury in the rat, outperforming blood urea nitrogen and serum creatinine as predictors of histopathological changes in the proximal tubule in response to many pathophysiological states or toxicants. Studies in man indicate that tissue expression and urinary excretion of the ectodomain of KIM-1 are sensitive and specific markers of injury as well as predictors of outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18569971     DOI: 10.1080/00365510802145059

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest Suppl        ISSN: 0085-591X


  55 in total

1.  A molecular classifier for predicting future graft loss in late kidney transplant biopsies.

Authors:  Gunilla Einecke; Jeff Reeve; Banu Sis; Michael Mengel; Luis Hidalgo; Konrad S Famulski; Arthur Matas; Bert Kasiske; Bruce Kaplan; Philip F Halloran
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

2.  Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective.

Authors:  Ming-Chang Hu; Mingjun Shi; Jianning Zhang; Henry Quiñones; Makoto Kuro-o; Orson W Moe
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

3.  MCP-1 gene activation marks acute kidney injury.

Authors:  Raj Munshi; Ali Johnson; Edward D Siew; T Alp Ikizler; Lorraine B Ware; Mark M Wurfel; Jonathan Himmelfarb; Richard A Zager
Journal:  J Am Soc Nephrol       Date:  2010-11-11       Impact factor: 10.121

Review 4.  Biomarkers of adverse drug reactions.

Authors:  Daniel F Carr; Munir Pirmohamed
Journal:  Exp Biol Med (Maywood)       Date:  2017-09-26

5.  Urinary NGAL and KIM-1: potential association with histopathologic features in patients with renal cell carcinoma.

Authors:  Amjad Shalabi; Zaid Abassi; Hoda Awad; Sarel Halachmi; Boaz Moskovitz; Yoram Kluger; Ofer Nativ
Journal:  World J Urol       Date:  2013-02-22       Impact factor: 4.226

Review 6.  Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers.

Authors:  Steven L Wood; Margaret A Knowles; Douglas Thompson; Peter J Selby; Rosamonde E Banks
Journal:  Nat Rev Urol       Date:  2013-02-26       Impact factor: 14.432

Review 7.  Enabling innovative translational research in acute kidney injury.

Authors:  Abolfazl Zarjou; Paul W Sanders; Ravindra L Mehta; Anupam Agarwal
Journal:  Clin Transl Sci       Date:  2011-12-07       Impact factor: 4.689

8.  Combined hydroxyurea and ETA receptor blockade reduces renal injury in the humanized sickle cell mouse.

Authors:  Crystal Taylor; Malgorzata Kasztan; Binli Tao; Jennifer S Pollock; David M Pollock
Journal:  Acta Physiol (Oxf)       Date:  2018-09-20       Impact factor: 6.311

9.  The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma.

Authors:  Jeremiah J Morrissey; Evan D Kharasch
Journal:  J Urol       Date:  2012-11-12       Impact factor: 7.450

10.  Assay validation for KIM-1: human urinary renal dysfunction biomarker.

Authors:  Shalini Chaturvedi; Takeisha Farmer; Gordon F Kapke
Journal:  Int J Biol Sci       Date:  2009-01-19       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.